Education
About Us
Working with TipRanks
Follow Us
Candel Therapeutics (CADL)
NASDAQ:CADL
Aglatimagene Besadenovec
Non Small Cell Lung Cancer
Phase II
Active Not Recruiting
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Jul 24, 2020
―
Nivolumab, Temozolomide, Radiation, Valacyclovir, Adv-Tk, Laboratory Biomarker Analysis
Glioma, Malignant
Phase I
Completed
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
May 24, 2018
―
Can-2409 + Valacyclovir
Lung Cancer
Phase I
Completed
Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Apr 24, 2017
―
Valacyclovir, Aglatimagene Besadenovec
Prostate Cancer
Phase II
Active Not Recruiting
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
May 06, 2016
―
Aglatimagene Besadenovec + Valacyclovir
Prostate Cancer
Phase III
Active Not Recruiting
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Sep 19, 2011
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Candel Therapeutics (CADL) have in its pipeline
CADL is currently developing the following drugs: Aglatimagene Besadenovec, Nivolumab, Temozolomide, Radiation, Valacyclovir, Adv-Tk, Laboratory Biomarker Analysis, Can-2409 + Valacyclovir. These drug candidates are in various stages of clinical development as the company works toward FDA approval.